A Systematic Review and Network Meta‐Analysis of Regorafenib and TAS‐102 in Refractory Metastatic Colorectal Cancer

BACKGROUND. Regorafenib at different dosing strategies and TAS‐102 are treatment options for refractory metastatic colorectal cancer (mCRC). We aimed to evaluate the comparative effectiveness evidence supporting these different strategies. MATERIALS AND METHODS. We searched different databases for r...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Sonbol, Mohamad Bassam, Benkhadra, Raed, Wang, Zhen, Firwana, Belal, Walden, Daniel J., Mody, Kabir, Hubbard, Joleen M., Murad, M. Hassan, Ahn, Daniel H., Bekaii‐Saab, Tanios
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2019
Assuntos:
Gastrointestinal Cancer
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6738316/
https://ncbi.nlm.nih.gov/pubmed/31164455
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0189
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados